Compare CPSS & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CPSS | EMBC |
|---|---|---|
| Founded | 1991 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.1M | 199.9M |
| IPO Year | 2010 | 2021 |
| Metric | CPSS | EMBC |
|---|---|---|
| Price | $9.34 | $3.59 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $18.50 |
| AVG Volume (30 Days) | 17.7K | ★ 1.2M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 6.88% |
| EPS Growth | 1.27 | ★ 20.90 |
| EPS | 0.24 | ★ 0.67 |
| Revenue | ★ $434,470,000.00 | N/A |
| Revenue This Year | $147.09 | $1.17 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $38.79 | ★ $5.70 |
| Revenue Growth | ★ 10.41 | N/A |
| 52 Week Low | $6.67 | $2.77 |
| 52 Week High | $10.49 | $15.55 |
| Indicator | CPSS | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 47.78 | 53.31 |
| Support Level | $8.85 | $3.07 |
| Resistance Level | $9.53 | $9.45 |
| Average True Range (ATR) | 0.29 | 0.16 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 53.64 | 54.12 |
Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.